Associate Director for Research on Women’s Health and Director of the ORWH at NIH, Janine A. Clayton, M.D., FARVO, will be speaking at the Society for Women’s Health Research’s (SWHR) “Women’s Unique Health Needs and the Sustainable Development Goals,” which is a series of sessions during the Science Summit at the United Nations General Assembly.
Top Stories
NIH has awarded $7,722,583 to Columbia University to oversee the new NEXUS: Network for Exposomics in the U.S. Coordinating Center for research on the human exposome, which is the cumulative measure of environmental exposures and corresponding biological responses.
NIH has announced the final winners of its Connecting the Community for Maternal Health Challenge. Eight nonprofit organizations will share approximately $1.5 million in cash prizes for their efforts to develop, implement, and conduct research projects to improve maternal health outcomes in their communities.
Polycystic Ovary Syndrome (PCOS) affects 6–15% of women in the United States and up to 20% of women who struggle with their weight. As part of PCOS Awareness Month, PCOS Challenge hosted a webinar on September 3, 2024, about research-driven innovations in PCOS care.
Researchers supported by the National Institutes of Health have found that measuring two types of fat in the bloodstream along with C-reactive protein (CRP), a marker of inflammation, can predict a woman’s risk for cardiovascular disease decades later.
In collaboration with the National Library of Medicine, the Office of Research on Women’s Health has released a Notice of Funding Opportunity (NOFO) to highlight interest in receiving grant applications that will fund the preparation of book-length manuscripts and other works of academic and/or public health policy value to U.S. health professionals, public health officials, biomedical researchers, and historians of the health sciences.
ORWH is pleased to announce the release of the National Academies of Sciences, Engineering, and Medicine (NASEM) Overview of Research Gaps for Selected Conditions in Women’s Health Research at the NIH: Proceedings of a Workshop—in Brief. This publication summarizes the third public meeting of NASEM’s ad hoc committee aiming to address the persistent gaps that remain in the knowledge of women's health research across the NIH.
ORWH is pleased to announce the recipients of the Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education Program (R25) grant, in collaboration with the Office of Aids Research, National Library of Medicine, National Institute of Neurological Disorders and Stroke, and Sexual & Gender Minority Research Office.
Private-sector innovation is a key aspect of accelerating and improving women’s health research. In response to President Biden’s Executive Order on Advancing Women’s Health Research and Innovation, NIH committed to further increasing—by 50%—its investments to support innovators and early-stage small businesses engaged in research and development on women’s health.
A new study sponsored by the National Institute of Allergy and Infectious Diseases has determined that cabotegravir, an antiretroviral medication used for HIV treatment, is safe for use before and during pregnancy. The global study analyzed the pregnancy and infant outcomes of using long-acting injectable cabotegravir (CAB-LA) in more than 300 pregnant women.